Dr. Edwin C. Kingsley, MD

Dr. Kingsley practices at Comprehensive Cancer Centers of Nevada in Las Vegas, Nevada.

Dr. Kingsley's NPI, 1336156199, was assigned on August 2, 2006. Dr. Kingsley graduated from University of Utah School of Medicine in 1980. Dr. Kingsley holds Nevada license 5208.

Dr. Kingsley's primary practice is Comprehensive Cancer Centers of Nevada, at 3730 S Eastern Ave, Las Vegas, NV 89169 in Clark County. The practice phone is (702) 952-3400.

Dr. Kingsley's primary practice is Comprehensive Cancer Centers of Nevada in Las Vegas, Nevada. Dr. Kingsley is also affiliated with Sunrise Hospital and Medical Center. The medical group on file is Comprehensive Cancer Centers of Nevada. Dmand AI also links Dr. Kingsley to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kingsley practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kingsley's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kingsley is licensed in Nevada.

CMS data shows 99,666 Medicare services from Dr. Kingsley across 76 procedure codes in 2024, for 949 Medicare patients. Medicare paid $1,161,556 for them. Every service was in an office.

CMS counts 949 Medicare patients who saw Dr. Kingsley in 2024. The largest group is 75 to 84, with 431 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kingsley's median patient age at 66, with 52% women.

In 2024, Dr. Kingsley wrote 1,688 Medicare Part D claims for 263 patients. 61% of them were for generic drugs. CMS names the drug for 1,331 of them, across 41 drugs with 11 or more claims each, at $7,467,148 in total drug cost. In 2023, CMS named 1,149 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Kingsley for performance year 2024, reported individually. Dr. Kingsley accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Kingsley, published from 2018 to 2024. 2018 was the busiest year, with 2. The most frequent topics are Leukemia, Lymphocytic, Chronic, B-Cell, Piperidines and Protein Kinase Inhibitors. Dr. Kingsley's most frequent co-authors are John McEvoy Burke, MD, Arvind Chaudhry, MD and Aileen Cleary Cohen, MD.

Dmand AI links Dr. Kingsley to 9 clinical trials, 3 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Leukemia, Lymphocytic, Chronic, B-Cell, Multiple Myeloma and Blood Protein Disorders. BeiGene sponsors the most, 3.

CMS Open Payments shows 323 general payments to Dr. Kingsley from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Daiichi Sankyo Inc. paid the most, $1,308. It also lists 4 research payments totaling $5,533 from 2019 to 2025.

Dr. Kingsley graduated from University of Utah School of Medicine in 1980.